Pharmaceutical Supply Chain Decarbonisation

Bring emissions visibility to global pharmaceutical supply chains.

Mavarick helps pharma manufacturers report Scope 3 emissions, engage suppliers at scale, and uncover carbon reduction opportunities across R&D, production, and distribution.

How It Works

Abstract pattern of interconnected hexagonal outlines in white and green on a black background.

Our impact

The Challenge

Pharma supply chains span raw materials, APIs, CDMOs, packaging & logistics.

Supplier response rates are low, leaving large Scope 3 data gaps.

Regulatory and investor pressure on sustainability is intensifying.

Lack of visibility undermines risk management and reputation.

Three factory workers in green uniforms and hairnets inspecting and sorting items at a packaging station with cardboard boxes in a clean production room.

The Mavarick Solution

Engage 1000s of suppliers automatically to fill Scope 3 data gaps.

Generate multi-framework reports for CSRD, CBAM, and GHG Protocol compliance.

Use predictive modelling to fill unavoidable gaps and ensure coverage.

Benchmark suppliers to identify carbon-efficient sourcing and logistics.

Key Use Cases

Black and white line drawing of a cow standing, seen from the side, facing right.

Graphic showing a sequence of three steps: Step 1 - Project Brief, Step 2 - Stakeholder Input, Step 3 - Job Requisition, with directional arrows indicating flow from one step to the next.

Product Carbon Footprinting

Scope 3 Reporting & Compliance

Supplier Engagement & Optimisation

Increase Scope 3 supplier response rates by 3x.

Achieve 99% coverage of upstream supplier data.

Strengthen ESG credibility with investors and regulators.

Real Stories, Real Results

Mavarick helped us cut supply chain emissions from raw materials by 6%, improve data accuracy by 20%, and strengthen supplier engagement through fully automated workflows

Purchasing and Warehouse Lead, Croom Medical

Request a Demo